X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs FULFORD INDIA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER FULFORD INDIA PFIZER/
FULFORD INDIA
 
P/E (TTM) x 24.6 398.8 6.2% View Chart
P/BV x 3.9 6.2 62.9% View Chart
Dividend Yield % 0.8 0.1 979.3%  

Financials

 PFIZER   FULFORD INDIA
EQUITY SHARE DATA
    PFIZER
Mar-16
FULFORD INDIA
Mar-14
PFIZER/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs2,724942 289.2%   
Low Rs1,611450 358.0%   
Sales per share (Unadj.) Rs440.9691.4 63.8%  
Earnings per share (Unadj.) Rs48.711.5 424.9%  
Cash flow per share (Unadj.) Rs75.815.4 493.3%  
Dividends per share (Unadj.) Rs15.002.00 750.0%  
Dividend yield (eoy) %0.70.3 240.8%  
Book value per share (Unadj.) Rs462.9380.0 121.8%  
Shares outstanding (eoy) m45.753.90 1,173.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.0 488.4%   
Avg P/E ratio x44.560.7 73.3%  
P/CF ratio (eoy) x28.645.3 63.1%  
Price / Book Value ratio x4.71.8 255.6%  
Dividend payout %30.817.4 176.5%   
Avg Mkt Cap Rs m99,1632,714 3,653.2%   
No. of employees `0002.90.4 650.7%   
Total wages/salary Rs m2,758505 546.0%   
Avg. sales/employee Rs Th6,981.76,073.0 115.0%   
Avg. wages/employee Rs Th954.51,137.4 83.9%   
Avg. net profit/employee Rs Th771.1100.7 765.9%   
INCOME DATA
Net Sales Rs m20,1702,696 748.0%  
Other income Rs m857125 683.7%   
Total revenues Rs m21,0282,822 745.2%   
Gross profit Rs m4,310-46 -9,288.4%  
Depreciation Rs m1,23915 8,149.3%   
Interest Rs m510 54.7%   
Profit before tax Rs m3,92354 7,225.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,79410 18,691.7%   
Profit after tax Rs m2,22845 4,983.8%  
Gross profit margin %21.4-1.7 -1,241.7%  
Effective tax rate %45.717.7 258.7%   
Net profit margin %11.01.7 666.3%  
BALANCE SHEET DATA
Current assets Rs m16,2991,738 937.6%   
Current liabilities Rs m7,594545 1,394.1%   
Net working cap to sales %43.244.3 97.5%  
Current ratio x2.13.2 67.3%  
Inventory Days Days6548 134.7%  
Debtors Days Days264 598.2%  
Net fixed assets Rs m8,62212 72,452.9%   
Share capital Rs m45839 1,173.1%   
"Free" reserves Rs m20,7221,443 1,436.1%   
Net worth Rs m21,1801,482 1,429.1%   
Long term debt Rs m250-   
Total assets Rs m29,1372,077 1,403.0%  
Interest coverage x755.56.7 11,249.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.71.3 53.3%   
Return on assets %7.72.6 293.6%  
Return on equity %10.53.0 348.7%  
Return on capital %19.04.3 441.2%  
Exports to sales %0.10-   
Imports to sales %17.524.5 71.5%   
Exports (fob) Rs m12NA-   
Imports (cif) Rs m3,526659 534.8%   
Fx inflow Rs m5217 300.3%   
Fx outflow Rs m140673 20.8%   
Net fx Rs m-88-656 13.5%   
CASH FLOW
From Operations Rs m3,43690 3,818.1%  
From Investments Rs m-6,991105 -6,683.5%  
From Financial Activity Rs m-619-14 4,388.7%  
Net Cashflow Rs m-4,174181 -2,312.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 3.8 197.4%  
FIIs % 4.9 0.1 4,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 21.2 111.8%  
Shareholders   85,207 4,783 1,781.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 23, 2017 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS